These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15301893)

  • 1. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
    Genth-Zotz S; Bolger AP; Kalra PR; von Haehling S; Doehner W; Coats AJ; Volk HD; Anker SD
    Int J Cardiol; 2004 Sep; 96(3):397-401. PubMed ID: 15301893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
    Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
    Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
    Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
    Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
    Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
    Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
    J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
    Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
    Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
    Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia.
    Xin X; Ren AJ; Zheng X; Qin YW; Zhao XX; Yuan WJ; Guo ZF
    Peptides; 2009 Dec; 30(12):2281-5. PubMed ID: 19666068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.
    Sharma R; Francis DP; Pitt B; Poole-Wilson PA; Coats AJ; Anker SD
    Eur Heart J; 2004 Jun; 25(12):1021-8. PubMed ID: 15191772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.
    Gong K; Zhang Z; Sun X; Zhang X; Li A; Yan J; Luo Q; Gao Y; Feng Y
    Am Heart J; 2006 Jan; 151(1):62-8. PubMed ID: 16368293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.
    Bruch C; Rothenburger M; Gotzmann M; Wichter T; Scheld HH; Breithardt G; Gradaus R
    Int J Cardiol; 2007 Jun; 118(3):375-80. PubMed ID: 17049387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
    Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
    Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia?
    Celik T; Yaman H
    Int J Cardiol; 2010 Oct; 144(2):319-20. PubMed ID: 19304331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.